Financial

IRADIMED CORPORATION Reports Record Fourth Quarter and Full Year of 2025 Financial Results and Increases its Regular Quarterly Cash Dividend to $0.20 Per Share from $0.17 Per Share

Financial by 0 comments

ORLANDO, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) — IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the quarter and year ended December 31, 2025. The Company is a leader in developing innovative magnetic resonance imaging (“MRI”) compatible medical devices and products. The Company is a provider of (i) non-magnetic intravenous (“IV”) infusion pump systems and (ii) non-magnetic patient vital signs monitoring systems that are each designed for use during MRI procedures.

Continue Reading →

TriSalus Life Sciences Appoints Veteran Healthcare Investor Michael Stansky to its Board of Directors

Financial by 0 comments

WESTMINSTER, Colo.–(BUSINESS WIRE)–TriSalus Life Sciences, Inc. (Nasdaq: TLSI) (“TriSalus” or the “Company”), an oncology-focused medical technology company advancing novel drug delivery technologies alongside standard-of-care therapies to improve outcomes for patients with solid tumors, today announced changes to its Board of Directors. TriSalus announced that Dr. Arjun “JJ” Desai, a member […]

Continue Reading →

Humacyte Announces New U.S. Department of Defense Funding for Procurement of Bioengineered Blood Vessels

Financial by 0 comments

DURHAM, N.C., Feb. 09, 2026 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissues at commercial scale, today announced that the recently adopted FY 2026 U.S. Department of Defense (DoD) Appropriations Act includes dedicated funding to support the evaluation and incorporation of biologic vascular repair technologies for the warfighters suffering from traumatic vascular injuries.

Continue Reading →

AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance

Financial by 0 comments

Physician-led Collaboration Reinforces Ongoing Regulatory Activity and Clinical Advancement Across the Cardiovascular Portfolio LATHAM, N.Y.–Feb. 3, 2026– AngioDynamics, Inc. (NASDAQ: ANGO), a medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced it will […]

Continue Reading →

Medtronic advances its innovation strategy with intent to acquire CathWorks

Financial by 0 comments

Deal demonstrates Medtronic’s commitment to expanding pipeline through strategic investments and targeted acquisitions Exercising option to acquire will bolster Medtronic’s interventional cardiology portfolio, expanding its leadership in transforming how cardiovascular disease is diagnosed and treated Medtronic’s intent to acquire follows a 2022 strategic partnership agreement with CathWorks GALWAY, Ireland, Feb. 3, 2026 /PRNewswire/ — Medtronic plc (NYSE:MDT), […]

Continue Reading →

Santé Ventures Raises $330 Million for Fifth Fund to Advance Breakthrough Healthcare Innovation

Financial by 0 comments

Firm exceeds $300 million target with Fund V; expands its base of limited partners; announces promotions of Dennis McWilliams and Omar Khalil to Managing Directors AUSTIN, Texas, Feb. 2, 2026 /PRNewswire/ — Santé Ventures, a leading early-stage healthcare and life sciences investment firm, today announced the close of its fifth fund with $330 […]

Continue Reading →
1 … 12 13 14 15 16 … 485